NCT05424419

Brief Summary

Bracing is an accepted standard therapy for idiopathic scoliosis at Cobb angle ranges between 25° and 45°. However, it is unclear, if a specifically tailored regimen of daytime and nighttime braces (=double brace) yields superior results compared to the standard treatment (single brace for day and night). These two treatment regimens were investigated in the study.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 1997

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 1997

Completed
22 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

June 15, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
Last Updated

June 27, 2022

Status Verified

June 1, 2022

Enrollment Period

22 years

First QC Date

June 15, 2022

Last Update Submit

June 22, 2022

Conditions

Keywords

scoliosisnighttime bracingfull-time bracingChêneau braceCharleston brace

Outcome Measures

Primary Outcomes (1)

  • primary correction

    Primary correction (%) of brace therapy (Cobb angle measurement)

    At study inclusion with initiation of brace therapy

Secondary Outcomes (1)

  • Cobb angle reduction

    2 years after deposition of the brace

Study Arms (2)

double-brace group

AIS patients with daytime and nighttime braces

Procedure: Brace therapy

single-brace group

AIS patients with a single brace for day and night

Procedure: Brace therapy

Interventions

Brace therapyPROCEDURE

A Chêneau-type brace was made to be worn as a full-time brace or during daytime only (double-brace group), whereas the nighttime brace was produced according to the Charleston approach.

double-brace groupsingle-brace group

Eligibility Criteria

Age10 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients with AIS were managed as recommended by SOSORT Consensus statement. Inclusion criteria were according to the Scoliosis Research Society criteria. Initial diagnostics included a clinical examination, standardized X-ray of the entire spine in standing position. Patients for whom cost coverage of double-brace therapy was denied by the health insurance company received a single full-day and nighttime Chêneau type brace treatment. All other patients received a Chêneau brace for daytime and a Charleston type nighttime bending brace. Patients who were prescribed the brace were instructed to wear it for 23 hours/day. Patients were seen at 6-month intervals, at which times we collected radiographic, clinical, orthotic, and self-reported data.

You may qualify if:

  • AIS
  • age between 10 and 15 years (y)
  • Risser's sign of 0-2
  • Cobb curvature angle of 25-40°
  • no previous treatment
  • compliance (at least 23 h wearing time)

You may not qualify if:

  • non-idiopathic scoliosis
  • Cobb curvature angle \>40°
  • \<10 years and \>15 years for initial treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Scoliosis

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2022

First Posted

June 21, 2022

Study Start

January 2, 1997

Primary Completion

December 31, 2018

Study Completion

December 31, 2020

Last Updated

June 27, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share